2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1316461916 PA
Verify on CMS →

ANGELLA MASHKABOVA, PA

Endocrinology, Diabetes & Metabolism Physician in NEW HYDE PARK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
176
Medicare Part D claims · 69 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ANGELLA MASHKABOVA, PA filed 176 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in NEW HYDE PARK, New York, prescribing 63% generic.

176
Part D claims, 2023
63%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANGELLA MASHKABOVA, PA's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

176 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ANGELLA MASHKABOVA, PA practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANGELLA MASHKABOVA, PA?

Quality data not reported

NPI registry status

Active

Issued 07/26/2017

NPI 1316461916

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

176 93% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in New York

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers

New York providers

Endocrinology, Diabetes & Metabolism Physician share within New York

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANGELLA MASHKABOVA, PA appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding PA credentials at 1985 MARCUS AVE # 100, NEW HYDE PARK, NY, 11042, with a listed phone of (855) 201-4988. NPI 1316461916 was issued on 07/26/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MASHKABOVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 176 prescription claims written by this provider, covering 69 Medicare beneficiaries and totaling roughly $65K in drug spend, split 37% brand-name and 63% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1985 MARCUS AVE # 100
NEW HYDE PARK, NY 11042

Provider Details

NPI 1316461916
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials PA
Gender Female
NPI Issued 07/26/2017

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ANGELLA MASHKABOVA, PA. To verify ANGELLA MASHKABOVA, PA's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ANGELLA MASHKABOVA, PA — brand share 37.0%
Specialty average (est.)

37% brand-name claims vs 63% generic, on 176 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

176
Total Claims
$65K
Total Drug Cost
69
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
259
Total Day Supply
7,099
Brand vs Generic
37% brand / 63% generic
Brand Drug Cost
$54K
Generic Drug Cost
$11K
Antibiotic Claims
12

Patient Demographics

Average Patient Age
75.7 years
Avg HCC Risk Score
2.21
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANGELLA MASHKABOVA, PA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Farxiga
Dapagliflozin Propanediol
19
Metformin Hcl
18
Levothyroxine Sodium
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ANGELLA MASHKABOVA, PA fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ANGELLA MASHKABOVA, PA's 176 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MASHKABOVA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANGELLA MASHKABOVA, PA's specialty?
ANGELLA MASHKABOVA, PA specializes in Endocrinology, Diabetes & Metabolism Physician and practices in NEW HYDE PARK, New York. Credentials: PA.
How much does ANGELLA MASHKABOVA, PA prescribe under Medicare Part D?
In 2023, ANGELLA MASHKABOVA, PA wrote 176 Medicare Part D claims totaling $65K in drug costs for 69 beneficiaries.
Where is ANGELLA MASHKABOVA, PA located?
ANGELLA MASHKABOVA, PA is located at 1985 MARCUS AVE # 100, NEW HYDE PARK, NY, 11042. Phone: (855) 201-4988.
What is ANGELLA MASHKABOVA, PA's NPI number?
ANGELLA MASHKABOVA, PA's National Provider Identifier (NPI) is 1316461916, issued on 07/26/2017.
Does ANGELLA MASHKABOVA, PA prescribe more brand-name or generic drugs?
ANGELLA MASHKABOVA, PA's prescribing is 37% brand-name and 63% generic drugs by claim count, with $54K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ANGELLA MASHKABOVA, PA prescribe most often?
Based on 2023 Medicare Part D data, ANGELLA MASHKABOVA, PA's most frequently prescribed drugs include Farxiga, Metformin Hcl, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANGELLA MASHKABOVA, PA accept Medicare?
ANGELLA MASHKABOVA, PA appears in CMS Medicare data with 176 Part D claims and 69 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANGELLA MASHKABOVA, PA's credentials?
ANGELLA MASHKABOVA, PA's NPI is 1316461916 with credentials PA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology